Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smoking Cessation and the Natural History of HIV-Associated Emphysema
Brief Summary: People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.


Options:
A: Arm Label: Nicotine-inclusive e-cigarettes; Type: EXPERIMENTAL; Interventions: Other: Electronic Cigarette and behavioural change support. | Arm Label: Nicotine-free e-cigarettes; Type: EXPERIMENTAL; Interventions: Other: Nicotine-Free Electronic Cigarette and behavioural change support. | Arm Label: Nicotine Replacement Therapy (NRT); Type: ACTIVE_COMPARATOR; Interventions: Other: Nicotine Replacement Therapy and behavioural change support. | Intervention Type: OTHER; Name: Electronic Cigarette and behavioural change support.; Assigned to Arm(s): Nicotine-inclusive e-cigarettes | Intervention Type: OTHER; Name: Nicotine-Free Electronic Cigarette and behavioural change support.; Assigned to Arm(s): Nicotine-free e-cigarettes | Intervention Type: OTHER; Name: Nicotine Replacement Therapy and behavioural change support.; Assigned to Arm(s): Nicotine Replacement Therapy (NRT)
B: Arm Label: Healthy Control - Non-smoking; Type: OTHER; Interventions: Other: Biological Control | Arm Label: Healthy Control - Smoker; Type: OTHER; Interventions: Other: Biological Control | Arm Label: HIV Smoking Cessation Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline tartrate, Drug: Nicotine Replacement Therapy | Arm Label: Motivational Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interview | Intervention Type: DRUG; Name: Varenicline tartrate; Assigned to Arm(s): HIV Smoking Cessation Arm | Intervention Type: DRUG; Name: Nicotine Replacement Therapy; Assigned to Arm(s): HIV Smoking Cessation Arm | Intervention Type: OTHER; Name: Biological Control; Assigned to Arm(s): Healthy Control - Non-smoking, Healthy Control - Smoker | Intervention Type: BEHAVIORAL; Name: Motivational Interview; Assigned to Arm(s): Motivational Intervention
C: Arm Label: ABDC; Type: EXPERIMENTAL; Interventions: Other: Myblu variant A, Other: Myblu variant B, Other: Myblu variant C, Other: Myblu variant D | Arm Label: BCAD; Type: EXPERIMENTAL; Interventions: Other: Myblu variant A, Other: Myblu variant B, Other: Myblu variant C, Other: Myblu variant D | Arm Label: CDBA; Type: EXPERIMENTAL; Interventions: Other: Myblu variant A, Other: Myblu variant B, Other: Myblu variant C, Other: Myblu variant D | Arm Label: DACB; Type: EXPERIMENTAL; Interventions: Other: Myblu variant A, Other: Myblu variant B, Other: Myblu variant C, Other: Myblu variant D | Arm Label: EFHG; Type: EXPERIMENTAL; Interventions: Other: Myblu variant E, Other: Myblu variant F, Other: Myblu variant G, Other: Myblu variant H | Arm Label: FGEH; Type: EXPERIMENTAL; Interventions: Other: Myblu variant E, Other: Myblu variant F, Other: Myblu variant G, Other: Myblu variant H | Arm Label: GHFE; Type: EXPERIMENTAL; Interventions: Other: Myblu variant E, Other: Myblu variant F, Other: Myblu variant G, Other: Myblu variant H | Arm Label: HEGF; Type: EXPERIMENTAL; Interventions: Other: Myblu variant E, Other: Myblu variant F, Other: Myblu variant G, Other: Myblu variant H | Intervention Type: OTHER; Name: Myblu variant A; Assigned to Arm(s): ABDC, BCAD, CDBA, DACB | Intervention Type: OTHER; Name: Myblu variant B; Assigned to Arm(s): ABDC, BCAD, CDBA, DACB | Intervention Type: OTHER; Name: Myblu variant C; Assigned to Arm(s): ABDC, BCAD, CDBA, DACB | Intervention Type: OTHER; Name: Myblu variant D; Assigned to Arm(s): ABDC, BCAD, CDBA, DACB | Intervention Type: OTHER; Name: Myblu variant E; Assigned to Arm(s): EFHG, FGEH, GHFE, HEGF | Intervention Type: OTHER; Name: Myblu variant F; Assigned to Arm(s): EFHG, FGEH, GHFE, HEGF | Intervention Type: OTHER; Name: Myblu variant G; Assigned to Arm(s): EFHG, FGEH, GHFE, HEGF | Intervention Type: OTHER; Name: Myblu variant H; Assigned to Arm(s): EFHG, FGEH, GHFE, HEGF
D: Arm Label: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B